Earnings Summary

Accelerate Diagnostics Inc’s revenue jumped 0.94% since last year same period to $3Mn in the Q4 2023. On a quarterly growth basis, Accelerate Diagnostics Inc has generated -9.06% fall in its revenue since last 3-months.

Accelerate Diagnostics Inc’s net profit jumped 12.16% since last year same period to $-13Mn in the Q4 2023. On a quarterly growth basis, Accelerate Diagnostics Inc has generated -1528.57% fall in its net profits since last 3-months.

Accelerate Diagnostics Inc’s net profit margin jumped 12.98% since last year same period to -433.33% in the Q4 2023. On a quarterly growth basis, Accelerate Diagnostics Inc has generated -1670.95% fall in its net profit margins since last 3-months.

Accelerate Diagnostics Inc’s earning per share (EPS) estimates for the current quarter stand at -0.72 - a -16.13% fall from last quarter’s estimates.

Accelerate Diagnostics Inc’s earning per share (EPS) estimates for the current year stand at -0.72.

Accelerate Diagnostics Inc’s earning per share (EPS) fell -478.57% since last year same period to -0.81 in the Q4 2023. This indicates that the Accelerate Diagnostics Inc has generated -478.57% annual rate of fall in its earning per share (EPS) in the last 4 quarters.

Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Accelerate Diagnostics Inc’s return on assets (ROA) stands at -0.62.

The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Accelerate Diagnostics Inc’s return on equity (ROE) stands at 0.